Continuous Glucose Monitoring in Children with Type 1 Diabetes Improves Well-Being, Alleviates Worry and Fear of Hypoglycemia.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Additional Information
    • Source:
      Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 100889084 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-8593 (Electronic) Linking ISSN: 15209156 NLM ISO Abbreviation: Diabetes Technol Ther Subsets: MEDLINE
    • Publication Information:
      Original Publication: Larchmont, NY : Mary Ann Liebert, Inc., c1999-
    • Subject Terms:
      Anxiety/*etiology ; Blood Glucose Self-Monitoring/*psychology ; Diabetes Mellitus, Type 1/*psychology ; Fear/*psychology ; Hypoglycemia/*psychology; Adolescent ; Blood Glucose/analysis ; Child ; Diabetes Mellitus, Type 1/blood ; Female ; Humans ; Hypoglycemia/etiology ; Male ; Parents/psychology
    • Abstract:
      Background: There is limited published evidence regarding the psychological effect of use of continuous glucose monitoring (CGM) in the pediatric population with type 1 diabetes mellitus on metabolic control, fear of hypoglycemia, and patient or carer well-being. The aim of this study was to evaluate the effects of CGM on patient and carer well-being, worry, fear of hypoglycemia, and glycemic control.
      Methods: Children aged >12 years independently completed the hypoglycemia fear survey (HFS). Parents and carers of children using CGM for a minimum of 12 months were asked to complete a modified version of the hypoglycemia fear survey for parents of young children (HFS-P) before and after CGM usage.
      Results: Sixteen patients (8 boys) were included with median age of 13.5 years (2-17 years) and use of CGM for a minimum of 12 months. There was no significant improvement in the glycated hemoglobin after 12 months of CGM usage. Parents of all 16 patients completed the HFS-P survey. Of 12 young people eligible (age >12 years), 11 returned the HFS survey. Significant improvement was seen in both parental and patient fear of hypoglycemia after CGM (P < 0.001 and P = 0.003, respectively).
      Conclusion: The use of CGM did not show any significant improvement in glycemic control after 12 months; however, parental and children's fear of hypoglycemia and worry were significantly reduced after the use of CGM. Larger studies on the psychological effects of CGM are warranted.
    • Contributed Indexing:
      Keywords: Anxiety; CGM; Fear; Hypoglycemia; Type 1 diabetes mellitus
    • Accession Number:
      0 (Blood Glucose)
    • Publication Date:
      Date Created: 20190221 Date Completed: 20200130 Latest Revision: 20200130
    • Publication Date:
      20240513
    • Accession Number:
      10.1089/dia.2018.0347
    • Accession Number:
      30785768